Search Results - Oded Shamriz
- Showing 1 - 11 results of 11
-
1
-
2
Novel targeted inhibition of the IL-5 axis for drug reaction with eosinophilia and systemic symptoms syndrome by Limor Rubin, Aviv Talmon, Yaarit Ribak, Asa Kessler, Yossi Martin, Tal Keidar Haran, Oded Shamriz, Oded Shamriz, Irit Adini, Yuval Tal
Published in Frontiers in Immunology (2023-04-01)Get full text
Article -
3
Benralizumab for adults with rare and off-label eosinophilic disorders: a 52-week prospective, single-center study by Aviv Talmon, Oded Shamriz, Oded Shamriz, Limor Rubin, Yaarit Ribak, Iris Aynor, Adam Nevo, Anna Elia, Meitav Ben Sion, Esther Forkosh, Alon Y. Hershko, Yuval Tal
Published in Frontiers in Immunology (2025-10-01)Get full text
Article -
4
Case Report: Clinical manifestations of uncommon monogenic disorders: revisiting activated phosphoinositide 3-kinase delta syndrome 2 by Oded Shamriz, Oded Shamriz, Amarilla Mandola, Amos J. Simon, Amos J. Simon, Atar Lev, Pierre Attal, Chen Nadler, Ortal Barel, Ortal Barel, Yulia Khavkin, Yulia Khavkin, Rachel Eisenberg, Raz Somech, Ori Toker
Published in Frontiers in Pediatrics (2025-04-01)Get full text
Article -
5
-
6
Dual biological treatments in immune-mediated disorders: a single center experience by Oded Shamriz, Elchanan Parnasa, Limor Rubin, Aviv Talmon, Yaarit Ribak, Isaam Hindi, Hagit Peleg, Ronit Confino-Cohen, Yuval Tal
Published in BMC Immunology (2025-04-01)Get full text
Article -
7
Targeted inhibition of the IL5 axis for immune checkpoint inhibitors eosinophilic-induced adverse events by Michal Lotem, Limor Rubin, Aviv Talmon, Yaarit Ribak, David Lavie, Hovav Nechushtan, Nadia Caplan, Oded Shamriz, Irit Adini, Yuval Tal
Published in Journal for ImmunoTherapy of Cancer (2024-10-01)Get full text
Article -
8
Metabolic reprogramming driven by Ant2 deficiency augments T Cell function and anti-tumor immunity in mice by Omri Yosef, Leonor Cohen-Daniel, Oded Shamriz, Zahala Bar-On, Wajeeh Salaymeh, Amijai Saragovi, Ifat Abramovich, Bella Agranovich, Veronika Lutz, Joseph Tam, Anna Permyakova, Eyal Gottlieb, Magdalena Huber, Michael Berger
Published in Nature Communications (2025-05-01)Get full text
Article -
9
Dupilumab for cancer-associated refractory pruritus by Aviv Talmon, MD, Shlomo Elias, MD, PhD, Limor Rubin, MD, Yaarit Ribak, MD, Eyal Ben Dori, MD, Oded Shamriz, MD, Michal Lotem, MD, Irit Adini, PhD, Yuval Tal, MD, PhD
Published in Journal of Allergy and Clinical Immunology: Global (2023-08-01)Get full text
Article -
10
First-in-class intranasal epinephrine spray for anaphylaxis: Dose finding clinical study by Tair Lapidot, PhD, Yuval Tal, MD, PhD, Dalia Megiddo, MD, Galia Temtsin Krayz, PhD, Carolina Abrutzky, BSc, Simcha Blotnick, PhD, Oded Shamriz, MD, Alon Hershko, MD, PhD, Yoseph Caraco, MD
Published in Journal of Allergy and Clinical Immunology: Global (2025-08-01)Get full text
Article -
11
Clinical significance of very high IgE levels (≥1000 IU/mL): Population-based study of 118,211 adults by Shay Nemet, MD, Daniel Elbirt, MD, Ramon Cohen, MD, Keren Mahlab-Guri, MD, Shira Bezalel-Rosenberg, MD, Ilan Asher, MD, Aviv Talmon, MD, Limor Rubin, MD, Yaarit Ribak, MD, Ruslan Sergienko, MHA, Udi Nussinovitch, MD, PhD, Yuval Tal, MD, PhD, Oded Shamriz, MD
Published in Journal of Allergy and Clinical Immunology: Global (2025-05-01)Get full text
Article
